Welcome!
Home DUKE-NUS Medical School
Healthcare
Boehringer Ingelheim to acquire assets, IP from Singapore biotech firm in deal worth more than US$1 bil
The deal is the largest for any biotech company in Singapore, and among the biggest globally for preclinical stage programmes.
January 09, 2020
Healthcare
Singapore's billion-dollar headache
SINGAPORE (Sept 18): How much does a migraine cost? The type of throbbing headaches cost Singapore some $1.04 billion last year, according to new research released Wednesday by the DUKE-NUS Medical School and Novartis.
September 18, 2019